What is it about?
Antigenic peptides in cancer immunotherapy.
Featured Image
Why is it important?
This article shows how two different HLA molécules can compete for showing an antigenic peptide, which has not been demonstrated before.
Perspectives
TNF-a tests show the competition between the two HLA molécules.
Dr Christophe Panichelli
Private practice, Sprimont, Belgium
Read the Original
This page is a summary of: A MAGE-3 peptide presented by HLA-B44 is also recognized by cytolytic T lymphocytes on HLA-B18, Tissue Antigens, July 2002, Wiley,
DOI: 10.1034/j.1399-0039.2002.600103.x.
You can read the full text:
Contributors
The following have contributed to this page
